Azienda Ospedaliera Ordine Mauriziano di Torino
12
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
8.3%
1 terminated/withdrawn out of 12 trials
80.0%
-6.5% vs industry average
8%
1 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
The Remeasure Trial
Role: lead
Clinical Effectiveness of an Off-the-shelf Single REnal Scalloped sTent-graft for HOstile NEck Infrarenal Abdominal Aortic Aneurysm
Role: collaborator
Early Treatment With Evolocumab in Patients With ST-elevation Myocardial Infarction
Role: collaborator
Influence of Ozone Therapy on Postoperative Pain Relief in the Surgical Treatment of Lower Third Molars: Randomized Controlled Trial
Role: lead
Comparison of the Efficacy and Tolerability of Femal Versus Placebo
Role: lead
CARotid plaqUe StabilizatiOn and Regression With Evolocumab.
Role: lead
OPPIuM Technique and Myolysis With Diode Laser Dwls
Role: collaborator
Covid Radiographic Images Data-set for A.I
Role: collaborator
Lung Ultrasound for Acute Dyspnea in Emergency Department
Role: collaborator
Effectiveness Of Symbiotic Therapy In Jaundiced Patients
Role: lead
Effectiveness of Routine Application Of Anterior Approach During Right Hepatectomy
Role: lead
Efficacy Study of Single Agent Trastuzumab or Lapatinib to Treat HER2-Overexpressing Breast Cancer
Role: lead
All 12 trials loaded